MDxHealth SA (OTCMKTS:MXDHF – Get Free Report) shares were down 9.1% on Monday . The stock traded as low as $0.25 and last traded at $0.25. Approximately 300 shares were traded during trading, a decline of 70% from the average daily volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Stock Down 9.1 %
The stock’s 50 day moving average is $0.25. The company has a debt-to-equity ratio of 1.45, a current ratio of 1.25 and a quick ratio of 1.19.
MDxHealth Company Profile
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Recommended Stories
- Five stocks we like better than MDxHealth
- Stock Average Calculator
- The Average 401k Balance by Age Explained
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Find and Profitably Trade Stocks at 52-Week Lows
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.